ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Benchmark maintains Buy rating on Synopsys after earnings beat

Synopsys posted fiscal Q3 2026 adjusted EPS of $3.91, topping estimates, while revenue reached $2.48 billion. Benchmark kept its $570 price target and Buy rating despite a post-market stock decline.

PA
Priya Anand · Equities & Earnings Desk · 2 Sept 2026 · 09:23 · 1 min read
Share
Benchmark maintains Buy rating on Synopsys after earnings beat

Synopsys reported fiscal third-quarter 2026 adjusted earnings of $3.91 per share, exceeding the $3.67 per share consensus estimate, while revenue totaled $2.48 billion against a $2.44 billion forecast. The company also raised its full-year outlook following the results.

Benchmark maintained its Buy rating and $570 price target on Synopsys stock, describing the quarter as a "beat-and-raise" despite the shares falling in after-hours trading. The firm noted that artificial intelligence acts as a tailwind for the company’s electronic design automation and simulation software segments, prompting a material upward revision to near-term estimates.

Baird upgraded Synopsys to Outperform from Neutral, lifting its price target to $560 from $558. The firm cited a favorable growth trajectory, projecting a return to double-digit organic revenue growth by fiscal 2027 and potential upside in revenue and free cash flow estimates.

Synopsys’ gross profit margin stood at 82.6%, while its forward earnings multiple was 24.0 times prior to the results, the lowest in years according to Benchmark. The company’s last twelve months revenue growth reached 39.5%. Synopsys has scheduled an analyst day for September 30, 2026.

InvestingPro analysis indicated the stock appears slightly overvalued relative to its Fair Value.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT